ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,307.16
0.41%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36844
-0.05%
Bitcoin
69,382.87
0.40%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Regenerx Biopharmaceuticals (RGN)

  7. Regenerx Biopharmaceuticals (RGN) News

RGN

Regenerx Biopharm In (RGN)

Regenerx Biopharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:RGN
DateTimeSourceHeadlineSymbolCompany
12/22/20108:16AMBusiness WireFirst Patient Screened in Phase 2 Trial with RegeneRx’s RGN-259 for Dry Eye SyndromeAMEX:RGNRegenerx Biopharmaceuticals
12/21/20103:31PMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
12/20/20109:00AMBusiness WireRegeneRx’s Scientific Advisory Board Member Receives 2011 Camras AwardAMEX:RGNRegenerx Biopharmaceuticals
12/09/20109:51AMBusiness WireRegeneRx Receives Mexican Patent for the Use of TB4 for Prevention and Treatment of Cardiac DamageAMEX:RGNRegenerx Biopharmaceuticals
12/01/20109:30AMBusiness WireRegeneRx Receives Australian Patent Using TB4 to Protect Against Biological, Chemical and Toxic AgentsAMEX:RGNRegenerx Biopharmaceuticals
11/30/201012:41PMBusiness WireResearchers Identify Potential Thymosin Beta 4 ReceptorAMEX:RGNRegenerx Biopharmaceuticals
11/17/20108:35AMBusiness WireRegeneRx Receives Australian Patent Using Tβ4 for Treatment Of Gastrointestinal DisordersAMEX:RGNRegenerx Biopharmaceuticals
11/16/20101:30PMBusiness WireRegeneRx President and CEO to Present at Maxim Group Growth ConferenceAMEX:RGNRegenerx Biopharmaceuticals
11/12/20105:09AMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
11/02/20106:30AMBusiness WireRegeneRx Reports Positive Results of Preclinical Dry Eye StudyAMEX:RGNRegenerx Biopharmaceuticals
11/01/20104:06PMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
11/01/20103:30PMBusiness WireRegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request HearingAMEX:RGNRegenerx Biopharmaceuticals
11/01/201011:56AMBusiness WireRegeneRx Awarded $733,438 from U.S. Government Under the Patient Protection and Affordable Care ActAMEX:RGNRegenerx Biopharmaceuticals
10/26/201010:07AMBusiness WireRegeneRx Announces Letter to Stockholders Posted on WebsiteAMEX:RGNRegenerx Biopharmaceuticals
09/14/20108:08AMBusiness WireRegeneRx Announces TB4 Stroke Study to be Honored at American Heart Association Scientific SessionsAMEX:RGNRegenerx Biopharmaceuticals
09/07/20109:35AMBusiness WireRegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment ConferenceAMEX:RGNRegenerx Biopharmaceuticals
09/03/20104:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
09/03/20104:22PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:RGNRegenerx Biopharmaceuticals
09/02/20107:44AMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
09/02/20106:00AMBusiness WireRegeneRx Appoints R. Don Elsey to Board of DirectorsAMEX:RGNRegenerx Biopharmaceuticals
08/20/20103:01PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:RGNRegenerx Biopharmaceuticals
08/13/20105:02AMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
08/02/20107:30AMBusiness WireBritish Researchers Report that TB4 is Essential to Heart DevelopmentAMEX:RGNRegenerx Biopharmaceuticals
07/21/20103:48PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)AMEX:RGNRegenerx Biopharmaceuticals
07/20/20104:26PMEdgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
07/19/201011:30AMBusiness WireResearchers Report in Neuroscience that TB4 Improves Neurological Function after StrokeAMEX:RGNRegenerx Biopharmaceuticals
07/16/20104:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
07/16/20104:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
07/16/20104:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
07/16/20104:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
 Showing the most relevant articles for your search:AMEX:RGN

Your Recent History

NASDAQ
CPSI
Computer Programs and Sy...
BIBX
MYRIAUSDT
Myria
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved